Elbit Med Tech (EMTC) — Cash Flow-to-Debt Ratio
Elbit Med Tech (EMTC) has a Cash Flow-to-Debt Ratio of 0.00x as of June 2021, meaning its operating cash flow of ILA-116.00K could theoretically repay 0% of its total liabilities (ILA38.54 Million) in one year. See Elbit Med Tech free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Elbit Med Tech Cash Flow-to-Debt Ratio (2008–2022)
Historical debt coverage capacity for Elbit Med Tech across 12 annual periods. Also explore Elbit Med Tech equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Elbit Med Tech (2008–2022)
Year-by-year debt coverage analysis for Elbit Med Tech. For market capitalisation and broader financial context, see Elbit Med Tech stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (ILA) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2022 | -1.01x | ILA-526.00K | ILA522.00K | ▼ -3.9% |
| 2021 | -0.97x | ILA-547.00K | ILA564.00K | ▼ -5219.8% |
| 2020 | -0.02x | ILA-674.00K | ILA36.97 Million | ▼ -61.2% |
| 2019 | -0.01x | ILA-571.00K | ILA50.48 Million | ▲ +1.3% |
| 2018 | -0.01x | ILA-499.00K | ILA43.52 Million | ▼ -61.8% |
| 2017 | -0.01x | ILA-301.00K | ILA42.48 Million | ▲ +10.1% |
| 2016 | -0.01x | ILA-293.00K | ILA37.18 Million | ▼ -2.7% |
| 2015 | -0.01x | ILA-261.00K | ILA34.00 Million | ▲ +43.6% |
| 2014 | -0.01x | ILA-443.00K | ILA32.56 Million | ▼ -36.9% |
| 2013 | -0.01x | ILA-336.00K | ILA33.82 Million | ▲ +83.2% |
| 2009 | -0.06x | ILA-9.38 Million | ILA158.28 Million | ▼ -1.4% |
| 2008 | -0.06x | ILA-10.79 Million | ILA184.65 Million | — |